Aduro Biotech, Inc. (NASDAQ: ADRO) announced highlights from a poster presentation at the Annual Meeting of the Society for Immunotherapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE